Assessment of QT interval prolongation in combined use of NM394, an active metabolite of prulifloxacin, and erythromycin
2004
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI